KRAS Kickers· @KRASKickers · X·· 3 天前评分45
正文
暂无中文译文，显示英文原文。
#ESMO26
#RAS #KRAS
443 浏览 · 5 赞 · 1 转发 · 0 回复
会议摘要
Calderasib monotherapy in various KRAS G12C–mutated advanced solid tumors: Results from the phase 1 KANDLELIT-001 study
https://esmocongress.esmo.orgKrascendo 3: A randomised, phase III trial in progress of divarasib vs immunotherapy or observation in patients with resected, stage II-IIIB, KRAS G12C+ non-small cell lung cancer
https://esmocongress.esmo.org2683P按 NSCLC, metastatic 对上
First-line (1L) olomorasib + pembrolizumab in KRAS G12C-mutant NSCLC: Updated results from LOXO-RAS-20001 and SUNRAY-01
https://esmocongress.esmo.orgWe’re excited for ESMO2026, where we’ll share subgroup analyses from RASolute 302 and connect with colleagues across the oncology community. Swipe through to see where you can find Revolution Medicines throughout the congress. #ForMediaOnly在 X 查看被引用的帖子
来源：KRAS Kickers · x.com